For a cirrhotic patient after large‑volume paracentesis, how should 20 g of albumin be administered—over 8 hours or more rapidly, and what is the optimal infusion duration?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Albumin Administration After Large-Volume Paracentesis

For a cirrhotic patient after large-volume paracentesis (>5 L), albumin should be infused after the procedure is completed—not during—at a dose of 8 g per liter of ascites removed, administered over 1–2 hours to avoid volume overload. 1, 2

Timing and Rate of Infusion

The albumin infusion should begin immediately after paracentesis completion and be delivered over 1–2 hours. 2 This timeframe balances the need for prompt volume expansion against the risk of circulatory overload, particularly in patients with cirrhotic cardiomyopathy. 2

  • The paracentesis itself should be completed rapidly over 1–4 hours, draining ascites to dryness in a single session. 1
  • Historical concerns about administering albumin over extended periods (such as 8 hours) are not supported by current evidence and may delay the prevention of post-paracentesis circulatory dysfunction (PICD). 2

Dosing Protocol

The mandatory dose is 8 g of albumin per liter of ascitic fluid removed when >5 L is evacuated. 1, 2

  • For a 5 L paracentesis: administer 40 g albumin (200 mL of 20% albumin or 160 mL of 25% albumin). 2
  • Use hyperoncotic solutions (20% or 25% albumin); 5% albumin is inadequate for this indication. 2
  • Albumin replacement is calculated solely on ascites volume removed, not patient body weight (except in spontaneous bacterial peritonitis). 2

Evidence Supporting Rapid Post-Procedure Administration

Albumin must be given after—not during—the paracentesis to effectively prevent PICD. 1, 2

  • Meta-analysis demonstrates that albumin reduces PICD incidence (OR 0.39,95% CI 0.27-0.55) compared to alternative treatments. 3
  • Albumin decreases hyponatremia (OR 0.58,95% CI 0.39-0.87) and mortality (OR 0.64,95% CI 0.41-0.98) versus other plasma expanders. 3
  • Without albumin, renal impairment occurs in approximately 21% of patients versus 0% with albumin replacement. 2

Common Pitfall: Prolonged Infusion Duration

Administering 20 g of albumin over 8 hours represents both underdosing and excessive infusion time for a typical large-volume paracentesis. 2

  • If 5 L was removed, the correct dose is 40 g (not 20 g), constituting a 50% underdose. 2
  • The 8-hour infusion timeframe is unnecessarily prolonged and delays the therapeutic benefit of volume expansion. 2
  • To correct underdosing, administer the remaining albumin promptly within hours of recognizing the error. 2

Post-Infusion Monitoring (6-Day Window)

Monitor for complications of inadequate albumin replacement: 2

  • Renal function: Daily serum creatinine; acute kidney injury is a recognized complication of under-replacement. 2
  • Electrolytes: Daily serum sodium; hyponatremia may develop with inadequate dosing. 2
  • Plasma renin activity: A >50% rise from baseline indicates early PICD. 2

Special Considerations for Smaller Volumes

For paracentesis <5 L, albumin replacement at 8 g/L can be considered (but is not mandatory) in patients with acute-on-chronic liver failure or high risk of post-paracentesis acute kidney injury. 1, 2

  • Synthetic plasma expanders may be used for volumes <5 L in uncomplicated cases, though albumin remains superior. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Maximum Volume for Single Paracentesis in Cirrhotic Ascites

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.